Trigeminal nerve (Fifth cranial nerve) (CN V)

The trigeminal nerve, also known as the fifth cranial nerve (CN V), is the largest and most complex cranial nerve, providing primary sensory innervation to the face and motor control for the muscles of mastication [16]. It consists of three major branches—the ophthalmic (V1), maxillary (V2), and mandibular (V3) nerves—which converge at the trigeminal ganglion before entering the brainstem [3, 11]. In clinical pharmacology, the trigeminal system is a critical site of pathology for conditions like trigeminal neuralgia, where vascular compression leads to focal demyelination and neuronal hyperexcitability [1, 14]. It also forms the core of the trigeminovascular system, a key pathway in the pathophysiology of migraine and cluster headaches [7, 9]. While the nerve itself is an anatomical structure rather than a single molecular target, it expresses several key therapeutic targets including voltage-gated sodium channels (Nav1.6, Nav1.7), calcium channels, and calcitonin gene-related peptide (CGRP) receptors [10, 15]. Drugs such as carbamazepine and sumatriptan modulate these specific molecular components to alleviate paroxysmal pain and neurogenic inflammation [13, 17].

Other names

Fifth cranial nerveNervus trigeminusCN VTrigeminal systemCranial nerve V

Pharmacological modulation of the trigeminal system primarily involves the stabilization of neuronal membranes through the blockade of voltage-gated sodium channels (e.g., carbamazepine, oxcarbazepine) or the inhibition of excitatory neurotransmitter release by targeting the alpha-2-delta subunit of voltage-gated calcium channels (e.g., gabapentin, pregabalin) [3, 10, 13]. Additionally, drugs targeting the trigeminovascular system, such as triptans and CGRP antagonists, act by inhibiting the release or activity of pro-inflammatory neuropeptides like calcitonin gene-related peptide (CGRP) and Substance P, which are mediators of neurogenic inflammation [4, 7, 9]. Local anesthetics like lidocaine provide acute relief by non-selectively blocking sodium channels along the nerve fibers to prevent signal propagation [17].